thyroxine has been researched along with No-Reflow Phenomenon in 1 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
No-Reflow Phenomenon: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madak, N | 1 |
| Nazlı, Y | 1 |
| Mergen, H | 1 |
| Aysel, S | 1 |
| Kandaz, M | 1 |
| Yanık, E | 1 |
| Cekdemir, D | 1 |
| Tavlı, T | 1 |
1 other study available for thyroxine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Acute phase reactants in patients with coronary slow flow phenomenon.
Topics: Aged; C-Reactive Protein; Coronary Angiography; Coronary Circulation; Cross-Sectional Studies; Femal | 2010 |